Key result
Long-term anticoagulation for unretrieved IVC filters is linked to a ~4% symptomatic DVT rate.
Why the study?
Although many patients with unretrieved IVC filters receive anticoagulation, their long-term prognosis regarding VTE recurrence and bleeding events remains unknown.
Does not-retrieval of IVC filters with continued anticoagulation increase death, VTE, or bleeding compared to filter retrieval in patients with IVC filters?
Cohort (n=195)
Yes
Does not-retrieval of IVC filters with continued anticoagulation increase death, VTE, or bleeding compared to filter retrieval in patients with IVC filters?
In patients with unretrieved IVC filters, appropriate long-term anticoagulation is associated with a low rate of recurrent VTE and no significant increase in major bleeding compared to patients with retrieved filters.
Answers are grounded in this paper and cite their sources.
Supports anticoagulation in unretrieved IVC filters; leaves open randomized trials versus retrieval.
Since permanent inferior vena cava (IVC) filters increase deep vein thrombosis (DVT), filter retrieval should be performed as possible. Despite the guideline recommendation, IVC filters are not always retrieved in clinical practice. To date, many patients with not-retrieval IVC filters have been prescribed anticoagulant therapy, but the long-term prognosis, including venous thromboembolism (VTE) and bleeding events, remains unknown. In this study, 195 patients who underwent IVC filter implantation between 2006 and 2017 at 3 institutions in Niigata City have been investigated about their deaths, VTE recurrence, and bleeding events. After peaking 2009, the number of IVC filter implantation gradually decreased. During observational period, there were 158 patients with not-retrieval IVC filters (the overall retrieval rate of 19.0%). The not-retrieval group included significantly older and more patients with cancer compared to the retrieval group. Anticoagulation therapy was continued in 88% of the not-retrieval group. During a mean follow-up of 5.0 years, 6 symptomatic DVT events associated with inadequate control of anticoagulation and 13 bleeding events were observed. A total of 52 patients died and only the presence of cancer was prognostic risk factor. Although long-term anticoagulation therapy may be associated with bleeding events, there were few recurrent VTE under optimal anticoagulation. It is anticipated that even if the IVC filter cannot be retrieved, appropriate anticoagulation is useful for prevention of DVT recurrence despite the risk of bleeding.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2022) conducted a cohort in Inferior vena cava filter implantation (n=195). Non-retrieval of IVC filter with anticoagulation vs. Retrieval of IVC filter was evaluated on Symptomatic DVT events. Long-term anticoagulation in patients with unretrieved IVC filters was associated with a 3.8% rate of symptomatic DVT and an 8.2% rate of bleeding events over a mean 5.0 years.
Synapse has enriched 10 related papers. Consider them for comparative context: